[1]涂小清.肺力咳合剂+阿莫西林克拉维酸钾治疗小儿急性支气管炎的临床效果[J].医学信息,2024,37(22):34-37.[doi:10.3969/j.issn.1006-1959.2024.22.008]
　TU Xiaoqing.Clinical Effect of Feilike Mixture+Amoxicillin and Clavulanate Potassium in the Treatment of Acute Bronchitis in Children[J].Journal of Medical Information,2024,37(22):34-37.[doi:10.3969/j.issn.1006-1959.2024.22.008]
点击复制

肺力咳合剂+阿莫西林克拉维酸钾治疗小儿急性支气管炎的临床效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年22期
页码:
34-37
栏目:
论著
出版日期:
2024-11-15

文章信息/Info

Title:
Clinical Effect of Feilike Mixture+Amoxicillin and Clavulanate Potassium in the Treatment of Acute Bronchitis in Children
文章编号:
1006-1959（2024）22-0034-04
作者:
涂小清
余江区人民医院儿科，江西 鹰潭 335200
Author(s):
TU Xiaoqing
Department of Pediatrics,Yujiang District People’s Hospital,Yingtan 335200,Jiangxi,China
关键词:
阿莫西林克拉维酸钾; 肺力咳合剂; 急性支气管炎; 炎症因子
Keywords:
Amoxicillin and clavulanate potassium; Feilike mixture; Acute bronchitis; Inflammatory factor
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2024.22.008
摘要:
目的 分析肺力咳合剂+阿莫西林克拉维酸钾在小儿急性支气管炎中的疗效及对炎症细胞因子的影响。方法 按照随机数字表法将2020年7月-2023年2月我院收治的62例小儿急性支气管炎患儿分为对照组和研究组，每组31例。对照组仅接受肺力咳合剂治疗，研究组接受肺力咳合剂+阿莫西林克拉维酸钾治疗。比较两组临床疗效、症状（发热、咳嗽、咳痰、肺部湿啰音）消失时间、炎症因子指标[C反应蛋白（CRP）、降钙素原（PCT）、白介素6（IL-6）、肿瘤坏死因子α（TNF-α）]、肺功能指标[用力肺活量（FVC）、呼气流量峰值（PEF）、第一秒用力呼气量（FEV1）]。结果 研究组治疗总有效率（96.77%）高于对照组（77.42%）（P＜0.05）；研究组发热、咳嗽、咳痰、肺部湿啰音消失时间较对照组缩短（P＜0.05）；两组治疗后CRP、PCT、TNF-α、IL-6水平较治疗前降低，且研究组CRP、PCT、TNF-α、IL-6水平较对照组降低（P＜0.05）；两组治疗后FEV1、FVC、PEF水平较治疗前升高，且研究组FEV1、FVC、PEF水平较对照组升高（P＜0.05）。结论 肺力咳合剂+阿莫西林克拉维酸钾治疗小儿急性支气管炎的效果确切，有利于快速消除患儿临床症状，改善患者肺功能以及炎症因子水平。
Abstract:
Objective To evaluate therapeutic impact of a combination therapy using Feilike mixture and amoxicillin-clavulanate on pediatric patients with acute bronchitis, along with its influence on inflammatory markers.Methods Using a random number table, 62 children diagnosed with acute bronchitis, who were admitted to our facility between July 2020 and February 2023, were categorized into two groups: a control group and a study group, with 31 children in each group. The control group received treatment solely with Feilike mixture, whereas the study group was administered a regimen that included both Feilike mixture and amoxicillin-clavulanate. The following parameters were compared between the two groups: clinical outcomes, duration until the resolution of symptoms (such as fever, cough, sputum production, and lung crackles), levels of inflammatory biomarkers [C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α)], and pulmonary function metrics [forced vital capacity (FVC), peak expiratory flow (PEF), and forced expiratory volume in one second (FEV1)].Results The study group demonstrated a superior overall efficacy rate of 96.77%, which was higher than the 77.42% observed in the control group (P<0.05). The study group also exhibited a faster resolution of symptoms, including fever, cough, lung moist rales, and sputum production, compared to the control group (P<0.05). After treatment, both groups showed a reduction in CRP, PCT, TNF-α, and IL-6 levels, but the study group had a more pronounced decrease (P<0.05). Similarly, while both groups experienced an improvement in FEV1, FVC, and PEF, the study group had a greater enhancement (P<0.05).Conclusion The combination of Feilike mixture and amoxicillin with clavulanate potassium for treating acute bronchitis in children yielded excellent results, markedly lowering serum inflammatory cytokine levels.

参考文献/References:

[1]范立东,李志军,马增光.阿莫西林克拉维酸钾联合枳桔二陈汤治疗儿童迁延性细菌性支气管炎的效果观察及对炎性因子、免疫功能的影响[J].临床误诊误治,2020,33(10):49-52.[2]孟巧霞.小儿肺咳颗粒联合阿莫西林克拉维酸钾治疗小儿急性支气管炎的疗效观察[J].现代诊断与治疗,2019,30(8):1249-1250.[3]蔡仪术,梁文宝,周焕娟.阿奇霉素序贯疗法应用于小儿支原体肺炎对症状改善及不良反应的影响[J]. 罕少疾病杂志,2021,28(3):57-58,100.[4]张特,罗小春,王斌,等.阿莫西林克拉维酸钾干混悬剂联合异丙托溴铵雾化吸入治疗支气管哮喘患者合并肺部感染的疗效[J].中华医院感染学杂志,2018,28(11):1654-1657.[5]陈秋香.阿莫西林克拉维酸钾治疗小儿上呼吸道感染的疗效及对急性蛋白标志物的影响[J].基层医学论坛,2023,27(22):91-93.[6]廖琼,朱橙,钟娇玲.阿莫西林克拉维酸钾联合穴位贴敷治疗小儿支气管肺炎的临床研究[J].上海医药,2023,44(6):27-30.[7]葛盘春.阿莫西林克拉维酸钾治疗儿童肺炎的临床疗效[J].医学信息,2022,35(6):135-137.[8]马洲,周杰新,李帅.枯草杆菌二联活菌颗粒联合阿莫西林-克拉维酸钾治疗新生儿肺炎有效性及对康复进程、炎性指标的影响[J].解放军医药杂志,2022,34(9):91-95.[9]张特,罗小春,王斌,等.阿莫西林克拉维酸钾干混悬剂联合异丙托溴铵雾化吸入治疗支气管哮喘患者合并肺部感染的疗效[J].中华医院感染学杂志,2018,28(11):1654-1657.[10]袁向尚.孟鲁司特钠联合阿莫西林克拉维酸钾序贯治疗小儿反复下呼吸道感染的疗效观察[J].药物评价研究,2023,46(4):861-865.[11]吴睿峰,刘小敏,傅伟,等.自拟宣肺止嗽汤联合小儿推拿对急性支气管炎(风热犯肺证)患儿临床疗效的影响[J].中国中医急症,2021,30(3):482-485.[12]黄艳青.肺力咳合剂联合孟鲁司特钠对急性支气管炎患儿血清炎症介质水平的影响[J].实用中西医结合临床,2023,23(14):109-112.[13]宋文烈,吴学典,庞祥华.肺力咳合剂联合盐酸氨溴索治疗小儿急性支气管炎效果、肺功能及不良反应分析[J].吉林医学,2022,43(10):2698-2700.[14]钟传飞.肺力咳合剂治疗急性支气管炎患儿的研究[J].实用中西医结合临床,2022,22(18):36-39.[15]金路.肺力咳合剂佐治小儿急性支气管炎75例临床评价[J].中国药业,2016,25(4):48-50.[16]田利军,柳庆明,唐乐,等.毫针点刺治疗急性支气管炎患儿疗效及对唾液SIgA含量的影响[J].现代中西医结合杂志,2021,30(35):3905-3908,3915.[17]董益民.肺力咳合剂联合头孢丙烯干混悬剂治疗小儿急性支气管炎的临床观察[J].基层医学论坛,2020,24(35):5091-5093.[18]毕斗星,张晓霞,彭粉花.清热宣肺止咳汤联合西医治疗急性支气管炎(痰热壅肺证)疗效观察[J].中国中医急症,2019,28(9):1627-1629.[19]杨静,李琳.宣肺化痰散瘀汤辅助孟鲁司特钠咀嚼片和吸入用布地奈德混悬液治疗痰热壅肺型急性支气管炎患儿的临床观察[J].河北中医,2022,44(8):1331-1334.[20]王少燕.肺力咳合剂联合孟鲁司特治疗小儿急性支气管炎49例临床研究[J].中国药物与临床,2019,19(12):2060-2062.[21]Keij FM,Kornelisse RF,Hartwig NG,et al.Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial[J].Lancet Child Adolesc Health,2022,6(11):799-809.

相似文献/References:

[1]葛盘春.阿莫西林克拉维酸钾治疗儿童肺炎的临床疗效[J].医学信息,2022,35(06):135.[doi:10.3969/j.issn.1006-1959.2022.06.034]
　GE Pan-chun.Clinical Efficacy of Amoxicillin and Clavulanate Potassium in the Treatment of Pneumonia in Children[J].Journal of Medical Information,2022,35(22):135.[doi:10.3969/j.issn.1006-1959.2022.06.034]
[2]曾小兰.阿莫西林-克拉维酸钾、左氧氟沙星治疗下呼吸道感染的疗效及成本-效果分析[J].医学信息,2022,35(18):77.[doi:10.3969/j.issn.1006-1959.2022.18.019]
　ZENG Xiao-lan.Efficacy and Cost-effectiveness Analysis of Amoxicillin-clavulanate Potassium and Levofloxacin in Treatment of Lower Respiratory Tract Infection[J].Journal of Medical Information,2022,35(22):77.[doi:10.3969/j.issn.1006-1959.2022.18.019]
[3]蔡文斌.阿莫西林克拉维酸钾联合雾化吸入治疗小儿支气管肺炎的效果及对PCT、CRP的影响[J].医学信息,2022,35(19):68.[doi:10.3969/j.issn.1006-1959.2022.19.018]
　CAI Wen-bin.Effect of Amoxicillin and Clavulanate Potassium Combined with Aerosol Inhalation on Children with Bronchial Pneumonia and Its Influence on PCT and CRP[J].Journal of Medical Information,2022,35(22):68.[doi:10.3969/j.issn.1006-1959.2022.19.018]
[4]郭志丽,刘改莲,贺 蓉.阿奇霉素、氨溴特罗联合肺力咳合剂对支原体感染患儿血常规及CRP水平的影响[J].医学信息,2023,36(09):124.[doi:10.3969/j.issn.1006-1959.2023.09.025]
　GUO Zhi-li,LIU Gai-lian,HE Rong.Effect of Azithromycin, Ambroxol Combined with Feilike Mixture on Blood Routine and CRP Level in Children with Mycoplasma Infection[J].Journal of Medical Information,2023,36(22):124.[doi:10.3969/j.issn.1006-1959.2023.09.025]
[5]黄宇佳.阿莫西林克拉维酸钾治疗扁桃体炎的临床疗效及对PCT、TNF-α及IL-6水平的影响[J].医学信息,2024,37(10):137.[doi:10.3969/j.issn.1006-1959.2024.10.029]
　HUANG Yu-jia.Clinical Efficacy of Amoxicillin and Clavulanate Potassium in the Treatment of Tonsillitis and its Effect on the Levels of PCT, TNF-α and IL-6[J].Journal of Medical Information,2024,37(22):137.[doi:10.3969/j.issn.1006-1959.2024.10.029]
[6]胡 彪,王文忠,胡忠腾.阿奇霉素联合肺力咳合剂治疗肺炎支原体肺炎的临床疗效及安全性[J].医学信息,2024,37(23):24.[doi:10.3969/j.issn.1006-1959.2024.23.005]
　HU Biao,WANG Wenzhong,HU Zhongteng.Clinical Efficacy and Safety of Azithromycin Combined with Feilike Mixture in the Treatment of Mycoplasma Pneumoniae Pneumonia[J].Journal of Medical Information,2024,37(22):24.[doi:10.3969/j.issn.1006-1959.2024.23.005]

更新日期/Last Update: 1900-01-01